证券日报网讯1月6日，汉王科技（002362）在互动平台回答投资者提问时表示，公司的AI血压计是基 于公司在人工智能方面的技术能力创新研发出来的智能监测产品，也是公司进入大健康领域的一个切入 口；血压计属于国家二类医疗器械，对于公司来说是一个新的业务领域，公司需要在做好产品的基础 上，做好市场推广工作，快速适应和把握相关市场机会，在产品研发和销售推广端投入较大，也会面临 一定的市场不确定性。大健康领域是千亿级的市场，在做好做强AI血压计产品的基础上，公司也会关 注大健康领域的其他机会，跟踪产品和行业，如有合适的机遇，也会择机行动。 ...

Core Insights - Ant Group has upgraded its organizational structure, transforming the "Digital Healthcare Division" into the "Healthcare Group," marking a significant shift in its AI strategy towards healthcare [1] - The AI health application AQ has been rebranded as "Ant Aifu," which has seen a surge in downloads, reaching the third position on the Apple App Store shortly after its release [1] Group 1: Product Features and User Engagement - The new version of "Aifu" introduces features like "Health Diary," "Health Goals," and "Health Reminders," focusing on user engagement and emotional connection with the AI [2] - Approximately 55% of "Aifu" users are from third and fourth-tier cities, with a significant portion being over 40 years old, indicating a diverse user base [2] - The company emphasizes the need for personalized, automated, and professional healthcare solutions, highlighting that the AI healthcare sector is still underdeveloped in addressing user pain points [2] Group 2: Data and Expert Collaboration - Ant Group's advantages in the medical AI field include high-quality medical data, a professional evaluation system, and deep collaboration with top experts [3] - The company has established a medical multimodal model system since 2023, which supports its AI health manager AQ and ranks first in authoritative lists like HealthBech and MedBech [3] - A team of 30,000 real doctors provides online consultation services on the "Aifu" platform, with over 500 renowned doctors, including six academicians, having their "AI avatars" on the platform [3] Group 3: Future Plans and Market Strategy - Ant Group is actively expanding its presence in the Guangdong-Hong Kong-Macao Greater Bay Area, with significant announcements expected in January [6] - The "Aifu" app has already launched versions in Hong Kong and Macau, with city-level intelligent systems in Guangzhou and Shenzhen now operational [6] - The company is exploring partnerships with hardware manufacturers to integrate AI into medical devices, such as blood pressure monitors and glucose meters [6] - The commercial model for these services remains under discussion, with the belief that value creation will lead to a viable business model [6]

Core Viewpoint - Ant Group has upgraded its AI health application AQ to "Ant Afu," marking a shift from a tool to a service-oriented approach, focusing on health companionship, health Q&A, and health services [2][3]. Group 1: Application Upgrade and Market Positioning - The upgraded "Afu" app has seen a surge in downloads, quickly reaching the 3rd position in the Apple App Store [2]. - Ant Group's health division has been elevated to one of the five core strategic sectors, indicating a strong commitment to the healthcare market [3]. - The company aims to address the growing health service demands of an aging population in China, which has surpassed 310 million people aged over 60 [4]. Group 2: User-Centric Features and Services - "Afu" is designed to act as a proactive health manager, providing reminders and support for lifestyle changes such as smoking cessation and exercise [5][6]. - The app connects users with over 300,000 real doctors and collaborates with more than 500 renowned physicians to enhance its service offerings [7]. - Ant Group emphasizes the importance of high-quality data and collaboration with medical experts to ensure the accuracy and reliability of its AI health services [8][13]. Group 3: Future Plans and Ecosystem Development - Ant Group is exploring partnerships with both B-end (hospitals) and G-end (health authorities) to create a comprehensive health service ecosystem [5]. - The company plans to integrate AI with hardware, such as AI blood pressure monitors and blood glucose meters, to better serve the elderly population [19]. - Future developments will focus on preventive health measures and lifestyle management, aiming to create a seamless health service experience from companionship to medical care [19].

Core Insights - The article highlights the severe reality of chronic disease management among the elderly in China, emphasizing the need for societal attention and action [1][2][8] Group 1: Chronic Disease Statistics - Chronic diseases account for 88.5% of total deaths in China, with 75.8% of individuals aged 60 and above suffering from one or more chronic conditions [1] - Among the elderly population, the prevalence of hypertension is 49%, but the control rate is only 7.6% [2] - By the end of 2024, the elderly population (aged 60 and above) in China is projected to reach 310 million, constituting 22% of the total population [8] Group 2: Elderly Health Management Challenges - Over 60% of elderly individuals live alone or only with a spouse, complicating health management [8] - More than 80% of elderly individuals frequently forget to take their medication, and less than 20% are aware of or have purchased chronic disease treatment and rehabilitation services [8] - 23% of chronic disease consultations are made by children on behalf of their elderly parents, indicating a gap in direct communication about health issues [8] Group 3: Technological Solutions by AQ - AQ has launched several features to assist in chronic disease management, including smart blood pressure and blood glucose monitoring, medication reminders, and health data sharing with family members [9][10] - The AI health application aims to create a "protective net" for elderly health management, allowing children to monitor and support their parents' health even from a distance [10] - AQ emphasizes the importance of technology in enhancing health management while also recognizing the irreplaceable value of personal companionship and care [10]